Improving treatment of pneumonia in children using lung ultrasound
Official title: ToolCAP: Novel Tools to Improve Management of Paediatric Community-Acquired Pneumonia
Run by Ecole Polytechnique Fédérale de Lausanne · NCT06670833 · Data updated 2026-11-12
This study is testing if using lung ultrasound can help doctors treat pneumonia in kids better and reduce the need for unnecessary antibiotics.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 60 Days to 12 Years |
| Sex | All |
| Enrollment | 4894 (estimated) |
| Sponsor | Ecole Polytechnique Fédérale de Lausanne Academic / other |
| Drugs / interventions | radiation |
| Locations | 9 sites (Dakar, Dakar and 8 other locations) |
| Status | Recruiting |
| Started | April 4, 2025 |
| Main results expected | July 30, 2027 |
| Study ends | August 31, 2027 |
| Registry record updated | October 5, 2026 |
| Trial ID | NCT06670833 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are children presenting with cough or difficulty breathing, along with specific respiratory rate criteria.
✕Probably not a fit
Patients who are experiencing severe respiratory distress or have been treated with antibiotics for more than 48 hours prior to enrollment may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The ToolCAP initiative aims to enhance the management of pediatric community-acquired pneumonia by utilizing lung ultrasound to assess lung infections in children. This approach seeks to determine whether ultrasound can help doctors make better decisions regarding antibiotic prescriptions, as many children with lung infections do not require antibiotics. The study will involve children presenting with symptoms of lung infections, and it will compare the outcomes of those receiving standard care versus those assessed with ultrasound. The goal is to reduce unnecessary antibiotic use and improve treatment outcomes.
Why it matters
Potential benefit: If successful, this study could lead to more accurate treatment of pneumonia in children, reducing unnecessary antibiotic prescriptions and improving patient outcomes.
How similar studies have gone: Other studies have shown promise in using ultrasound for diagnosing pneumonia, suggesting that this approach may be effective, though this specific application is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Cough OR Difficulty Breathing AND, * One of the below: Fast breathing (tachypnoea) \> 50/minute (2-12 months) \> 40/minute (1-\<5 years) \> 25/minute (5-12 years) OR Lower chest wall indrawing Exclusion Criteria: * Presenting for repeat visit/follow-up of a treated lower respiratory tract infection (index illness / non-acute) or enrolled in the study within the preceding 28 days. * Received antibiotic treatment for more than 48 hours at the time of enrolment. * WHO IMCI danger signs (inability to drink/breastfeed, vomiting everything, convulsions with this illness, lethargy/unconscious). * Presence of jaundice. * Hypoxaemia with oxygen saturation (SpO2) \<88% * Oxygen saturation (SpO2) \<90% (or country-specific / altitude-adjusted thresholds) i) With signs of severe respiratory distress (such as nasal flaring, grunting, etc.) OR ii) In children \< 6 months * Requiring non-invasive ventilatory support (i.e., high-flow, bilevel positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP)) * Underlying disease associated with increased risk of severe pneumonia or pneumonia of unusual aetiology (e.g., WHO acute malnutrition requiring antibiotics as per local guidelines, severe immunodeficiency) * HIV positive participant that is either i) less than 12 months old; OR ii) requires admission for this illness; OR iii) known to be uncontrolled on treatment (with a documented VL \>1000c/ml in the previous 6 months) * Caregiver unavailable at the time of enrolment, or unwilling, to provide informed consent.
Where it's running
-
Université Cheikh Anta Diop
Dakar, Dakar, Senegal Recruiting -
Centre National Hospitalier d'Enfants Albert Royer
Dakar, Senegal Recruiting -
Centre De Santé Gaspard Kamara
Dakar, Senegal Recruiting -
Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Stellenbosch University
Parow, Cape Town, South Africa Recruiting -
University of Witwatersrand, MRC/Wits Rural Public Health and Health Transitions Research Unit
Parktown, Johannesburg, South Africa Recruiting -
Tintswalo Hospital
Acornhoek, Mpumalanga, South Africa Recruiting
Show 3 more locations
-
Themba Hospital
Mbombela, South Africa Recruiting -
Muhimbili University of Health and Allied Sciences
Dar es Salaam, Tanzania Recruiting -
Ifakara Health Institute
Ifakara, Morogoro, Tanzania Not yet recruiting
Study contacts
- Study coordinator: Kristina Keitel, MD, PhD
- Email: Kristina.Keitel@epfl.ch
- Phone: +41763432520
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Urine Pneumococcal Antigen Test in Children with Pneumonia
This study tests a non-invasive urine test to see if it can detect pneumococcal pneumonia and identify serotypes in children under five in Malawi.
-
Lung ultrasound to guide antibiotic decisions in children with pneumonia
This will see if using lung ultrasound for children aged 3–10 with suspected pneumonia leads to fewer antibiotic prescriptions than usual care.
-
Respiratory Physiotherapy in Critically Ill Pneumonia Patients
This study tests whether a structured breathing and chest therapy program can change inflammatory biomarkers in adults with pneumonia in the ICU compared to usual care.
-
AI-powered CT help to guide pneumonia care
A multicenter trial tests whether using a chest CT–based AI report to guide care reduces death or need for new organ support in adults with pneumonia.
-
Wintergreen oil inhalation for shortness of breath in pneumonia patients
Hospitals will test whether inhaling wintergreen essential oil helps relieve dyspnea in adults with pneumonia.
-
Optimising Antibiotic Use for Paediatric LRTIs in Africa
This study tests whether using point-of-care CRP tests together with the PREPARE score can safely reduce antibiotic use in infants aged 2–24 months with lower respiratory infections in a Johannesburg hospital.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.